Patent ID: 11865106
Assignee: SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating or reducing inflammatory bowel disease, comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition consisting of:
(a) berberine, or a chloride, sulfate or citrate salt thereof,
(b1) ethyl ester of eicosapentaenoic acid,
(b2) ethyl ester of docosahexaenoic acid, and
(c) a pharmaceutically acceptable excipient, carrier or diluent,, wherein
the weight ratio of (a) to (b1) and (b2) is about 1:3,
the weight ratio of ethyl ester of eicosapentaenoic acid to ethyl ester of docosahexaenoic acid is from about 1:2 to about 2:1, and
the pharmaceutical composition does not contain any active agent that elicits a biological response, other than the said (a), (b1) and (b2).